Are innovations in healthcare recognized for their true value ?
Oct 10, 2024 | 2:25 PM CEST - 2:55 PM CESTBULLE LA FRENCH CARE
Oct 10, 2024 | 2:25 PM CEST - 2:55 PM CEST
BULLE LA FRENCH CARE
Description
The valuation criteria for unicorns in the healthcare sector are beneficial to biotechs but don't give neither medtech nor digital health solutions the chance to reveal their true value. At the same time, funds are fighting against the idea that finance shouldn't be the main criterion for valuating companies in health. How can the paradigms shift in order to find the true value of innovation in healthcare?
